ASKA Pharmaceutical Co., Ltd.
↗Tokyo, Japan
ASKA Pharmaceutical is a leading Japanese specialty pharmaceutical company with a history spanning over 100 years. It is a subsidiary of ASKA Pharmaceutical Holdings Co., Ltd. and is recognized as a pioneer in hormone preparations. The company focuses on three core therapeutic areas: Obstetrics and Gynecology (Women's Health), Internal Medicine (Gastroenterology and Thyroid), and Urology.
ASKA holds a dominant market position in Japan for thyroid treatments, with its product Thyradin maintaining a nearly 98% market share. The company is actively expanding its global footprint, particularly in Southeast Asia, through strategic acquisitions and partnerships. It operates a major research hub at the Shonan Health Innovation Park (Shonan iPark) to accelerate drug discovery through open innovation.
CLASSIFICATION
Company Type:Biotech
Therapeutic Areas:
Industry:Pharmaceuticals
Sub-Industry:Hormone Therapeutics & Women's Health
SIZE & FINANCIALS
Employees:501-1000
Revenue:$400M-$500M (64.1B JPY)
Founded:1920
Ownership:subsidiary
Status:operating
FUNDING
Stage:Public
STOCK
Exchange:TSE
Ticker:4886
Market Cap:~$500M - $600M (75B JPY)
PIPELINE
Stage:Commercial
Lead Drug Stage:Commercial (Relumina, Thyradin)
Modalities:Small molecule, Hormone therapy, Digital therapeutics
Active Trials:13
Trial Phases:Phase 1: 3 | Phase 2: 2 | Phase 3: 2
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Parent Company:ASKA Pharmaceutical Holdings Co., Ltd.
Subsidiaries:ASKA Animal Health Co., Ltd., ASKA Pharma Medical Co., Ltd., Ha Tay Pharmaceutical Joint Stock Company (Vietnam)
Key Partnerships:Takeda Pharmaceutical (Relugolix co-development), Myovant Sciences (Relugolix licensing), Teijin Pharma (Joint research in gynecology), Kyorin Pharmaceutical (AKP-009 joint development)
COMPETITION
Position:Leader
Competitors:Takeda Pharmaceutical, Fuji Pharma, Mochida Pharmaceutical, Kissei Pharmaceutical
LEADERSHIP
Key Executives:
Sohta Yamaguchi - President and Representative Director
Takashi Yamaguchi - President, ASKA Pharmaceutical Holdings
Scientific Founders:Yasohachi Yamaguchi
Board Members:Takashi Yamaguchi, Sohta Yamaguchi, Masaya Takanashi
LINKS
Website:aska-pharma.co.jp
LinkedIn:LinkedIn Profile
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with ASKA Pharmaceutical Co., Ltd.. The information on this page was collected and compiled using AI agents from publicly available sources. While we strive for accuracy, this data may be incomplete, outdated, or contain errors. For official information, please visit the company's website directly. If you notice any inaccurate information, please contact us.